phase readout
saveNCT06629779: A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
RECRUITINGupdated 11h ago
community read0 votes
Sponsor: Pfizer. Phase: PHASE3. Conditions: Metastatic Castration-Resistant Prostate Cancer
view source ↗
comments(0)
5-min edit window · permanent after that